NASDAQ: AUPH

Aurinia Pharmaceuticals Inc.

Rosen Law Firm, a global investor rights law firm, announces the filing of a class action lawsuit on behalf of purchasers of the securities of Aurinia Pharmaceuticals Inc. (NASDAQ: AUPH) between May 7, 2021 and February 25, 2022, inclusive (the “Class Period”). A class action lawsuit has already been filed. If you wish to serve as lead plaintiff, you must move the Court no later than June 14, 2022.

If you purchased Aurinia securities between May 7, 2021 and February 25, 2022 and would like to join the action, please click “Join This Class Action.”

Class Period:May 7, 2021 through February 25, 2022

If you purchased Aurinia securities you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement.

Details of the case:

According to the lawsuit, defendants throughout the Class Period made false and/or misleading statements and/or failed to disclose that:

Aurinia was experiencing declining revenues;
Aurinia’s 2022 sales outlook for LUPKYNIS would fall well short of expectations;
accordingly, the Company had significantly overstated LUPKYNIS’s commercial prospects;
as a result, the Company had overstated its financial position and/or prospects for 2022; and
as a result, the Company’s public statements were materially false and misleading at all relevant times.

No Class Has Been Certified. Until a class is certified, you are not represented by counsel unless you retain one. You may select counsel of your choice. You may also remain an absent class member and do nothing at this point. An investor’s ability to share in any potential future recovery is not dependent upon serving as lead plaintiff.

Attorney Advertising. Prior results do not guarantee a similar outcome.